1747 OPIOID EFFECTS ON LUNG MATURATION IN FETAL RABBITS

C. Comer,J. S. Grunstein,R. Mason,M. Grunstein
DOI: https://doi.org/10.1203/00006450-198504000-01765
IF: 3.953
1985-04-01
Pediatric Research
Abstract:Based on the observations that the incidence of respiratory distress syndrome is less in infants of opiate-addicted mothers, and that amniotic fluid and fetal cord blood endorphins are increased during late gestation, we tested the hypothesis that endogenous opioids modulate fetal lung development. Pregnant rabbits received daily intramuscular injections, from days 18 to 28 of gestation, of either morphine sulfate (MS) (1.0 mg/kg), naloxone (NLX) (0.4 mg), or saline (C). Their fetuses, delivered prematurely on day 28 (term ∼ 31 days), were assessed for differences in their lung static pressure-volume (P-V) characteristics and morphology. The mean (± SE) deflation lung volume at transthoracic pressure (PT) = 5 cm H2O (V5), expressed as a percentage of the lung volume at PT = 40 (V40), amounted to 70.9 (± 4.3), 52.9 (± 5.8), and 33.9 (± 7.3)% in the MS, C, and NLX fetuses, respectively. Thus, relative to the C group, the MS fetuses had P-V curves displaced significantly (p < .05) upward and to the left, indicating increased alveolar stability; whereas the curves of the NLX fetuses were displaced significantly (p < .05) downward and to the right, demonstrating decreased alveolar stability. Moreover, relative to the C lungs, the MS lungs also appeared more mature histologically, having thinner alveolar septa and a greater airspace-to-tissue ratio. In contrast, the NLX lungs were less developed. These data provide evidence that opiate agonists accelerate intrauterine lung development, whereas opiate antagonists delay lung maturation. These findings suggest that lung development may be significantly modulated by endogenous opioids.
What problem does this paper attempt to address?